This information is about a targeted therapy called axitinib, which is also known as Inlyta®. It is used to treat a type of kidney cancer called renal cell cancer (RCC). RCC is cancer that has spread outside the kidney (advanced kidney cancer).
It’s best to read this information with our general information about kidney cancer.
Axitinib may be used to treat other types of cancer as part of a clinical trial.